Effect of a medical food on body mass index and activities of daily living in patients with Alzheimer's disease: Secondary analyses from a randomized, controlled trial

Journal of Nutrition, Health and Aging

Volumn 15, Issue 8, 2011, Pages 672-676

  Kamphuis, P J G H ^a,b   Verhey, F R J ^c   Olde Rikkert, M G M ^d   Twisk, J W R ^e   Swinkels, S H N ^a   Scheltens, Philip ^f  

^a DANONE RESEARCH   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

activities of daily living; Alzheimer's disease; BMI; nutrition; treatment outcome

Indexed keywords

AGED; ALZHEIMER DISEASE; ALZHEIMERS DISEASE COOPERATIVE STUDY-ACTIVITIES OF DAILY LIVING SCALE; ARTICLE; BEVERAGE; BODY MASS; COGNITION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; SOUVENAID; THERAPY EFFECT;

EID: 81455155460     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-011-0339-3     Document Type: Article

References (29)

1. Rosenstein LD. Differential diagnosis of the major progressive dementias and depression in middle and late adulthood a summary of the literature of the early 1990s. Neuropsychol Rev. 1998 Sep;8(3): 109-167. (Pubitemid 28554535)
2. Selkoe DJ. Alzheimer's disease is asynaptic failure. Science 2002;298:789-791. (Pubitemid 35231524)
3. Terry RD. Alzheimer's disease and the aging brain. J Geriatr Psychiatry Neurol. 2006 Sep;19(3): 125-128. (Pubitemid 44154851)
4. Wurtman RJ, UIus EH, Cansev M, et al. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 2006 May 9;1088(1):83-92. (Pubitemid 43729416)
5. Cansev M, Wurtman RJ, Sakamoto T, et al. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S153-S168.
6. Cansev M, Wurtman RJ. Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience. 2007 Aug 24;148(2):421-431. (Pubitemid 47364815)
7. Van Wijk NW, Böhlke M, Maher TT, et al. Combined dietary vitamins B6, B12, and folate increase plasma choline levels in rats. Abstract. 2011;10th International Conference of Alzheimer's and Parkinson's Diseases (AD/PD), Spain, Barcelona Program number 194.
8. Broersen LM, De Wilde M, I. L, et al. Reduced beta-amyloid plaque burden and neurodegeneration in APP/PS1 transgenic mice following multi-nutrient dietary intervention Society for Neuroscience (San Diego, CA). 2007;Programme number 157. 116/U127.
9. Barberger-Gateau P, Raffaitin C, Letenneur L, et al. Dietary patterns and risk of dementia the Three-City cohort study. Neurology. 2007 Nov 13;69(20):1921-1930. (Pubitemid 350100350)
10. Luchsinger JA, Tang MX, Miller J, et al. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol. 2007 Jan;64(1):86-92. (Pubitemid 46072428)
11. Shatenstein B, Kergoat MJ, Reid I. Poor nutrient intakes during 1-year follow-up with community-dwelling older adults with early-stage Alzheimer dementia compared to cognitively intact matched controls. J Am Diet Assoc. 2007 Dec;107(12):2091-2099. (Pubitemid 350166192)
12. Scheltens P, Kamphuis PJ, Verhey FR, et al. Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial. Alzheimers Dement. 2010 Jan;6(1):1-10e1.
13. Barberger-Gateau P, Commenges D, Gagnon M, et al. Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc. 1992 Nov;40(11):1129-1134.
14. White H, Pieper C, Schmader K. The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc. 1998 Oct;46(10):1223-1227. (Pubitemid 28467424)
15. Guerin O, Andrieu S, Schneider SM, et al. Different modes of weight loss in Alzheimer disease: a prospective study of 395 patients. Am J Clin Nutr. 2005 Aug;82(2):435-441.
16. Faxen-Irving G, Basun H, Cederholm T. Nutritional and cognitive relationships and long-term mortality in patients with various dementia disorders. Age and Ageing. 2005 Mar;34(2):13641. (Pubitemid 40331094)
17. Spaccavento S, Del Prete M, Craca A, et al. Influence of nutritional status on cognitive, functional and neuropsychiatrie deficits in Alzheimer's disease. Arch Gerontol Geriatr. 2009 May-Jun;48(3):356-360.
18. Ousset PJ, Nourhashemi F, Reynish E, et al. Nutritional status is associated with disease progression in very mild Alzheimer disease. Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):66-71. (Pubitemid 351651400)
19. Cook Z, Kirk S, Lawrenson S, et al. Use of BMI in the assessment of undernutrition in older subjects: reflecting on practice. Proc Nutr Soc. 2005 Aug;64(3):313-317. (Pubitemid 41160758)
20. (CHMP) CfMPfHU. Guideline on Medicinal Products for the Treatment of Alzheimer's Disease and Other Dementias (Document CPMP/EWP/553/95 Rev 1). London, UK: European Medicines Agency; 2009.
21. Mohs RC, Knopman D, Petersen RC, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11Suppl 2: S13-21.
22. Galasko D, Bennett D, Sano M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11Suppl 2:833-839.
23. Irving GF, Freund-Levi Y, Eriksdotter-Jonhagen M, et al. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study. J Am Geriatr Soc. 2009 Jan;57(1):11-17.
24. Gauthier S, Lopez OL, Waldemar G, et al. Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease. IntPsychogeriatr. 2010 Sep;22(6):973-983.
25. Galanos AN, Pieper CF, Comoni-Huntley JC, et al. Nutrition and function is there a relationship between body mass index and the functional capabilities of community-dwelling elderly? J Am Geriatr Soc. 1994 Apr;42(4):368-373. (Pubitemid 24116332)
26. Guerin O, Soto ME, Brocker P, et al. Nutritional status assessment during Alzheimer's disease: results after one year (the REAL French Study Group). J Nutr Health Aging. 2005;9(2):81-84. (Pubitemid 40478063)
27. de Jong N, Chin APMJ, de Groot LC, et al. Functional biochemical and nutrient indices in frail elderly people are partly affected by dietary supplements but not by exercise. J Nutr. 1999 Nov;129(11):2028-2036. (Pubitemid 29506381)
28. Faxen-Irving G, Basun H, Cederholm T. Nutritional and cognitive relationships and long-term mortality in patients with various dementia disorders. Age Ageing. 2005 Mar;34(2):136-141. (Pubitemid 40331094)
29. Chin A Paw MJ, Dekker JM, Feskens EJ, et al. How to select a frail elderly population? A comparison of three working definitions. J Clin Epidemiol. 1999 Nov;52(11): 1015-1021. (Pubitemid 29469803)